skip to content

Department of Oncology

 
Read more at: Report highlights inequalities and hidden suffering among people living with breast cancer

Report highlights inequalities and hidden suffering among people living with breast cancer

8 May 2024

c-coles.jpg A Lancet Commission led by Professor Charlotte Coles, Department of Oncology, University of Cambridge, UK, a National Institute for Health and Care Research (NIHR) Research Professor and Oncology Consultant at Cambridge University Hospitals NHS Foundation Trust, has reported that many people with breast cancer...


Read more at: The Lancet Commission on Breast Cancer publishes recommendations for change

The Lancet Commission on Breast Cancer publishes recommendations for change

8 May 2024

coles_charlotte_march_2022.jpg Many people with breast cancer are ‘systematically left behind’ due to inaction on inequities and hidden suffering, according to the report. At the end of 2020, 7.8 million women were alive having been diagnosed with breast cancer in the previous five years; this reflects progress in research...


Read more at: Improving risk stratification in smoking-related lung cancer

Improving risk stratification in smoking-related lung cancer

8 May 2024

New research has shown that the underlying genetic background influences how people respond to cigarette smoke and can affect lung cancer risk. This study, published in Genome Medicine (link is external) , involved analysis of differences in gene expression in cells lining the nose of smokers with and without lung cancer...


Read more at: Rebecca Fitzgerald receives OBE for services to cancer

Rebecca Fitzgerald receives OBE for services to cancer

6 March 2023

rebeccaobe_250.png Professor Rebecca Fitzgerald (Department of Oncology and Director of the Early Cancer Institute) has received an Officer of the Order of the British Empire (OBE) for services to cancer for her research in development of new methods of early detection of oesophageal cancer. Rebecca was recognised in the...


Read more at: Daniel Muñoz Espín wins PROSE award

Daniel Muñoz Espín wins PROSE award

6 March 2023

Daniel Muñoz Espín wins PROSE award Congratulations to Daniel Muñoz Espín (Department of Oncology, Early Cancer Institute), whose new book has been awarded a prestigious PROSE award by the Association of American publishers. Since 1976 the PROSE awards have been honouring scholarly works in a number of categories across...


Read more at: Harveer Dev awarded $1 million Challenge grant from the Prostate Cancer Foundation

Harveer Dev awarded $1 million Challenge grant from the Prostate Cancer Foundation

17 February 2023

h-dev.jpg Congratulations to Dr Harveer Dev and colleagues from the University of Cambridge and the Knight Cancer Institute at OHSU who have been awarded a $1 million Challenge grant by the Prostate Cancer Foundation for their project entitled First-In-Man PARP1-selective inhibitor in lethal prostate cancer: mechanisms of...


Read more at: Cambridge Cancer Research Hospital New Milestone

Cambridge Cancer Research Hospital New Milestone

17 February 2023

ccrh_main_entrance.png A full planning application to build a new specialist cancer research hospital for the region on the Cambridge Biomedical Campus has been submitted to Cambridge City Council. The Cambridge Cancer Research Hospital (CCRH) project will change the story of cancer for patients and their families, by...


Read more at: First UK proton beam therapy trial for breast cancer launches

First UK proton beam therapy trial for breast cancer launches

17 February 2023

coles.jpg The PARABLE trial will compare proton beam therapy – which can target radiotherapy beams more precisely – with standard radiotherapy for patients who are at greater risk of long-term heart problems after radiotherapy treatment. It will help to determine whether proton beam therapy can help to deliver adequate...


Read more at: Rebecca Fitzgerald Cancer Research Horizons Award

Rebecca Fitzgerald Cancer Research Horizons Award

17 February 2023

r-fitzgerald.jpg Rebecca Fitzgerald has received the Cancer Research UK (CRUK) Impact Recognition Award. CRUK CEO Michelle Mitchell presented the award to Rebecca and paid tribute to her outstanding and ongoing contribution to oncology, and her determination to drive forward the translation and commercialisation of her...


Read more at: Cambridge Experimental Cancer Medicine Centre funding award

Cambridge Experimental Cancer Medicine Centre funding award

17 February 2023

A team led by Bristi Basu (Department of Oncology, CUH and CRUK Cambridge Centre Pancreatic Cancer Programme Co-lead) and Duncan Jodrell (Department of Oncology and Cambridge Cancer Trials Centre Director) will receive around £3 million over the next five years for Cambridge’s Experimental Cancer Medicine Centre (ECMC)...